Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.

Autor: Valayer S; Infection, Antimicrobials, Modelling, Evolution (IAME), Université Sorbonne Paris Nord, Université Sorbonne Paris Cité, and Institut national de la santé et de la recherche médicale (Inserm), Paris, France.; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France., Alexandre M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France., Prague M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France., Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR) de Mafèrinyah, Ministère de la Santé et de l'Hygiène Publique, Mafèrinyah, Guinea., Doumbia S; University Clinical Research Center, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Kieh M; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia., Greenwood B; London School of Hygiene & Tropical Medicine (LSHTM), London, UK., Leigh B; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone., Poupelin M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France., Schwimmer C; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France., Sow SO; Centre pour le Développement des Vaccins, Ministère de la Santé et du Développement Social du Mali, Bamako, Mali., Berry IM; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, MD, USA., Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, MD, USA., Fusco D; French Agency for Research on AIDS and Viral Hepatitis (ANRS), Emerging Infectious Diseases, PariSanté Campus, Paris, France.; Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Cauwelaert ND; Inserm, Paris Cedex 13, France., Watson-Jones D; London School of Hygiene & Tropical Medicine (LSHTM), London, UK., Thiébaut R; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Lévy Y; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; Inserm, Paris Cedex 13, France.; Service d'Immunologie Clinique et Maladies Infectieuses, Hôpital Henri-Mondor, Créteil, France., Yazdanpanah Y; Infection, Antimicrobials, Modelling, Evolution (IAME), Université Sorbonne Paris Nord, Université Sorbonne Paris Cité, and Institut national de la santé et de la recherche médicale (Inserm), Paris, France.; Inserm, Paris Cedex 13, France.; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, Paris, France., Richert L; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Lhomme E; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Aboulhab J; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Aguirre-MacKenzie M BS; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Akoo P MB, ChB; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Akpa E MSN, MPH, RN; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Akpata R; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Albert S BA, MPH; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Ale BM MD, MSc, MPH; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Alimamy-Bangura S MB, ChB; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone, Andong P MSt; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Andrews BC; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Anoma S; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Atri N MPH, CPH; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Augier A MCom; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Awuondo K MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Ayouba A; (AF0130) Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090, Montpellier, France, Badio M MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Bagayoko A; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Balde A MPH; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Balssa J PharmD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF018) ANRS Emerging Infectious Diseases, Paris, France, Bangura LM BSc; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone, Barrington K MPA; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Barte de Saint Fare E BA; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Baseler B MS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Bauder A BA, PMP; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Bauduin C MSc; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Bawo L MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Beavogui AH MD, PhD; (AF019) Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea, Belson M BS; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Ben-Farhat S MEng; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Bererd M BS; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Bernaud N MSc; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Beyslow T PharmD; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Biai N MSc; (AF0130) Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090, Montpellier, France, Billioux J; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Billouin-Frazier S MSc; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Binachon B MD, MPH; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Blie J MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Bockstal V; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Boison P MS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Bolay F; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Boly A MM; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Bonawitz RE MD, MS; (AF0122) Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street Baltimore, MD, 21201-1509, USA, Borg AG MCM; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Bosompem S PharmD, MSc; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Bozman C MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Brady T MPH; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Browne S RN, BSN; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Bullis R; (AF0122) Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street Baltimore, MD, 21201-1509, USA, Cagniard B; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Cahill K RN, MSc, CCRC, RAC; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Cai Y; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Camara AA MSc; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Camara AK; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Camara AM; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Campagne A; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Campion C MSc; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Cantan A BSc; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France; (AF0129) Univ. Bordeaux, INSERM, MART, UMS 54, F-33000, Bordeaux, France, Cash J BS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Chai SP BBio-MedSc; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Chambelin F MHist; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Chea M BSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Chêne G MD, PhD; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Choi E; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Chouinard M MSW; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Chung F; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Chung L PharmD; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Ciancia S MJ; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Cisse PN; (AF0114) Département de Sociologie, FLSH, Université Cheikh Anta DIOP, Dakar, Sénégal, Cline-Cole E MA; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Colin C MSc; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Coller BA; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Conde DS; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Cone K, Cone K MSW, LCSW-C, C-SWHC; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Connor L MS; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Connor N MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Cooper JB MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Couffin-Cardiergues S; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Coulibaly F BS; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Coulibaly M PharmD, MSc; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Crew P PharmD, MPH, BCPS; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Dabakuyo-Yonli S PharmD, PhD; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Dabitao D PharmD, PhD; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Damerval T; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Davis B MPH; (AF015) School of Public Health, University of Minnesota, Minneapolis, MN, USA, Deen GF MD, MSc; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone, Dekeyster E; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Delfraissy JF MD, PhD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Delmas C MSc; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Diakite M PharmD, DPhil; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Diallo A MD, MPH; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF018) ANRS Emerging Infectious Diseases, Paris, France, Diallo FA; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Diallo MS MD, MPH; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Diarra A MSc; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Diarra S MSc, PhD; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Diawara O BS; (AF0119) Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali, Dighero-Kemp B BSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Diop S MSc, PhD; (AF0121) Liberia Institute for Biomedical Research Ethics Committee/National, Monrovia, Liberia, Diouf W; (AF0114) Département de Sociologie, FLSH, Université Cheikh Anta DIOP, Dakar, Sénégal, Dixit S; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Djenabou B MSc; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Doepel L BA; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, D’Ortenzio E MD, MPH; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF018) ANRS Emerging Infectious Diseases, Paris, France; (AF017) AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, Paris, F-75018, France, Doumbia S MD, PhD; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Doumbia MM; (AF0119) Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali, Douoguih M MD, MPH; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Dozier N MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Cauwelaert ND; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF018) ANRS Emerging Infectious Diseases, Paris, France, DuChêne A BS; (AF015) School of Public Health, University of Minnesota, Minneapolis, MN, USA, Duvenhage M NDIPIT; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Eckes R RN; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Elliott E MSc; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Enria L; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Espérou H; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Etienne C MSc; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Eyler A HSD; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Fakoli L MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Fallah M; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Fauvel MA MSc; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Faye S; (AF0114) Département de Sociologie, FLSH, Université Cheikh Anta DIOP, Dakar, Sénégal, Fayiah J MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Fleck S; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Fofana V BComp; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Tchos KF MD, MPH; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Franklin K MPhil, MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Fusco D; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Gaddah A; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Gaignet M MSc; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Gallagher K; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Gardner J BS; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Gichini H MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Gozalbes JG; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Grandits G MS; (AF015) School of Public Health, University of Minnesota, Minneapolis, MN, USA, Gray M BPharm; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Greenwood B; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Grobler N; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Gross R MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Grue L RN, BS, BSN; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Grund B; (AF0127) School of Statistics, University of Minnesota, Minneapolis, MN, USA, Guindo O MSc, PharmD; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Gupta S DrPH, MPH; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Haidara F; (AF0119) Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali, Hamz B PharmD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Hancox E MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Hébert JC MSL; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Hendriks J; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Hensley P MPh; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Hensley LE PhD, MSPH; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Herpin B MSN; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Higgs E MD, DTMH, MIA; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Hilton T BPharm, MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Hneino M; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Höeltermann TA BSc, MPH; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Holley HP; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Hoover M; (AF0116) Advanced BioMedical Laboratories, L.L.C., 1605 Industrial Hwy, Cinnaminson, NJ, USA, Howard N; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Hughes M BA, MBA, CPM, PMP; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Ilo D MD, MPH; (AF0120) University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali, Irvine S BS; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Ishola D MD, PhD; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Jato Y MPH; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Joe M MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Johnson M MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Kaba AS; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Kagan J; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Kallon K MSc; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Kamara M MBChB, MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Kante M BS; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Katoudi J MD, MPH; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Keita CM; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Keita S; (AF0115) Agence Nationale de Sécurité Sanitaire, Conakry, Guinea, Keita S; (AF0122) Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street Baltimore, MD, 21201-1509, USA, Kennedy SB MD, MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Keshinro B MBBS, FWACP; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Kiawu H MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Kieh M MD, MSMHC; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Killinger B BA; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Kinda M MD, MBA; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Kirchoff M PharmD, MSc, MBA; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Kocher G MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Kodio M PharmD; (AF0119) Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali, Kohn B BSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Koivogui L PharmD, PhD; (AF0123) INSP (Institut Nationale de Santé Publique), Conakry, Guinea, Kojan R; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Koli CF é, PharmD; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Koli JS é, MD; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Kollie D BSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Kopka S MS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Koroma B BPharm; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone, Kowuor D BSc, MSc, PhD; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Kpayieli-Freeman C MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Kwast L MSc; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Lacabaratz C; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF0118) Vaccine Research Institute, Univ. Paris Est Créteil, Henri Mondor Hospital, Créteil, France, Lacarra B; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Lambert L BS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Lambeth C BS; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Lancrey-javal S PharmD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF018) ANRS Emerging Infectious Diseases, Paris, France, Lane HC; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, Langba S BSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Lawal B MSc; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Lee AW; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Lee S; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Lees S; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Lefevre A; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Leigh B MD, MSc; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone, Lemarcis F; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Lévy Y MD, PhD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France; (AF0118) Vaccine Research Institute, Univ. Paris Est Créteil, Henri Mondor Hospital, Créteil, France, Levy-Marchal C; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Leyssen M MD, PhD; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Lhomme E MD, PhD; (AF0126) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform and U1219 BPH Inria Sistm, F-33000, Bordeaux, France, Liang J MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Linga M MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Liu K; (AF0112) Merck Sharp & Dohme Corp, Inc., Kenilworth, NJ, USA, Lowe B MPhil; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Lysander J MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Mahamadou I PharmD; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Maljkovic-Berry I; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Mambiah M ASc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Manno D MD, PhD; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Marchand J MS; (AF012) National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Marron L MSc; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, Massaquoi MB MD, MSc; (AF0110) Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia, Masson L MIBL; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Matard C BS; (AF014) Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, F-33000, Bordeaux, France, Mazur S BS; (AF0128) Integrated Research Facility at Fort Detrick (IRF-Frederick), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Fort Detrick, Frederick, MD, USA, McCullough J BS; (AF0116) Advanced BioMedical Laboratories, L.L.C., 1605 Industrial Hwy, Cinnaminson, NJ, USA, McFadyen K MPH; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, McLean C; (AF0113) Janssen Vaccines and Prevention BV Leiden, The Netherlands, Mercier N PharmD; (AF011) French Institute for Health and Medical Research (Inserm), 75013, Paris, France, Michavila P BBus; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Miller T RN, BSN; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Millimouno NP; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Miranda A MS; (AF0117) Leidos Biomedical Research, Inc., Frederick, MD, 21704, USA, Mohamed S BJ; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Mooney T BA; (AF013) London School of Hygiene & Tropical Medicine, London, UK, Muamba D; (AF016) The Alliance for International Medical Action, Alima, B.P.15530, Dakar, Sénégal, Mulbah J BPharm; (AF0111) College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone

Publikováno v: Emerging microbes & infections [Emerg Microbes Infect] 2025 Dec; Vol. 14 (1), pp. 2432353. Date of Electronic Publication: 2024 Dec 09.